Evidence map›Paper›PMID 33017498›Full record

SynthesisHuman brain mapping2022

Intracranial and subcortical volumes in adolescents with early-onset psychosis: A multisite mega-analysis from the ENIGMA consortium.

Tiril P Gurholt, Vera Lonning, Stener Nerland, Kjetil N Jørgensen, Unn K Haukvik, Clara Alloza, Celso Arango, Claudia Barth, Carrie E Bearden, Michael Berk and 32 more

Open access · goldAbstract readMeta-AnalysisMulticenter Study
In one paragraph

Synthesis in Human brain mapping, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Increased Brain-Age Gap in Young Adults With Psychotic Experiences.Biological psychiatry global open science · 2026
    Article
  8. Neuroanatomical Correlates of Negative Symptoms in Schizophrenia.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 18 institutions in 8 countries.

Tiril P GurholtNorwegian Center for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-1272-7616
Vera LonningNorwegian Center for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Stener NerlandNorwegian Center for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Kjetil N JørgensenNorwegian Center for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Unn K HaukvikNorwegian Center for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-0363-4127
Clara AllozaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.
Celso ArangoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.
Claudia BarthNorwegian Center for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0001-6544-0945
Carrie E BeardenDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, California, USA.
Michael BerkIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.
Hannes BohmanCenter for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden, Stockholm, Sweden.
Orwa DandashIMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Victoria, Australia.
Covadonga M Díaz-CanejaDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.ORCID 0000-0001-8538-3175
Carl T EdbomCenter for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden, Stockholm, Sweden.
Theo G M van ErpClinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, California, USA.
Anne-Kathrin J FettDepartment of Psychology, City, University of London, London, UK.
Sophia FrangouDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Benjamin I GoldsteinCenter for Youth Bipolar Disorder, Sunnybrook Health Science Center, Toronto, Ontario, Canada.
Anahit GrigorianCenter for Youth Bipolar Disorder, Sunnybrook Health Science Center, Toronto, Ontario, Canada.
Neda JahanshadImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.
Anthony C JamesDepartment of Psychiatry, University of Oxford, Oxford, UK.
Joost JanssenDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, Madrid, Spain.
Cecilie JohannessenNorwegian Center for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Katherine H KarlsgodtDepartment of Psychology, UCLA, Los Angeles, California, USA.
Matthew J KemptonDepartment of Psychosis Studies, King's College London, London, UK.
Peter KochunovMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Lydia KrabbendamDepartment of Clinical, Neuro and Developmental Psychology, VU Amsterdam, Amsterdam, Netherlands.
Marinos KyriakopoulosDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.ORCID 0000-0002-4594-2646
Mathias LundbergCenter for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden, Stockholm, Sweden.
Bradley J MacIntoshHurvitz Brain Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.ORCID 0000-0001-7300-2355
Bjørn Rishovd RundDepartment of Psychology, University of Oslo, Oslo, Norway.
Runar E SmelrorNorwegian Center for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0001-8611-6132
Alysha SultanDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Christian K TamnesNorwegian Center for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0002-9191-6764
Sophia I ThomopoulosDepartment of Psychiatry and Pharmacology, University of Toronto, Canada.ORCID 0000-0002-0046-4070
Ariana VajdiDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, California, USA.
Kirsten Wedervang-ResellNorwegian Center for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-2856-5412
Anne M MyhreChild and Adolescent Psychiatry Unit, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ole A AndreassenNorwegian Center for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Paul M ThompsonDepartment of Psychiatry and Pharmacology, University of Toronto, Canada.
Ingrid AgartzNorwegian Center for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
ENIGMA-EOP Working Group
University of Oslo · NOOslo University Hospital · NONeurobehavioral Systems · USSunnybrook Health Science Centre · CAUniversidad Complutense de Madrid · ESUniversity of Toronto · CADeakin University · AUKing's College London · GBUppsala University · SEAmsterdam Neuroscience · NLHospital General Universitario Gregorio Marañón · ESIcahn School of Medicine at Mount Sinai · USInstitute of Physics · GBKarolinska Institutet · SEOxford Health NHS Foundation Trust · GBUniversity of California, Irvine · USUniversity of Maryland, Baltimore · USUniversity of Southern California · US

Funding

STRESS AND EMOTIONAL REACTIVITYP50MH066286 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YEE-BRADBURY, CINDY M. · 2003 to 2014
$18.6M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Psychophysiological Precursors of AlcoholismR01AA012207 · NIAAA · UNIV OF ARKANSAS FOR MED SCIS · PI ACHESON, ASHLEY, KOCHUNOV, PETER V. · 2001 to 2025
$9.0M
SOLAR-Eclipse Computational Tools for Imaging GeneticsR01EB015611 · NIBIB · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KOCHUNOV, PETER V. · 2012 to 2024
$5.0M
Brain connectivity and the role of myelin in PsychosisR01MH113619 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FRANGOU, SOPHIA · 2018 to 2021
$2.5M
Multimodal Imaging of Executive and Reward Networks Across the Psychosis SpectrumR01MH101506 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KARLSGODT, KATHERINE HELEN · 2013 to 2017
$2.5M
ENIGMA-SD: Understanding Sex Differences in Global Mental Health through ENIGMAR01MH116147 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2018 to 2021
$2.5M
A global alliance to unlock brain mechanisms influencing suicidal behaviors through the ENIGMA ConsortiumR01MH117601 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JAHANSHAD, NEDA, SCHMAAL, LIANNE · 2018 to 2021
$1.5M
DNA damage response and DDBR01AG024138 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAYCHAUDHURI, PRADIP · 2005 to 2009
$1.4M
Redefine Trans-Neuropsychiatric Disorder Brain Patterns through Big-Data and Machine LearningRF1MH123163 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI KOCHUNOV, PETER V., THOMPSON, PAUL M · 2021 to 2021
$1.2M
Hybrid GPU/CPU Computing Resource to Support Connectomic and GenomicsS10OD023696 · OD · UNIVERSITY OF MARYLAND BALTIMORE · PI KOCHUNOV, PETER V. · 2018 to 2018
$593k
Integration of Five Large-Scale Neuropsychiatric Genetic Datasets under the RDoC FrameworkR03MH105808 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E, FEARS, SCOTT C. · 2015 to 2016
$154k
Medical Research Council G0500092NIBIB NIH HHS R01 EB015611NIBIB NIH HHS U54 EB020403NIH HHS MH105808NIH HHS P50MH066286NIH HHS R01EB015611NIH HHS R01MH101506NIH HHS R01MH113619NIH HHS R01MH116147NIH HHS R01MH117601NIH HHS S10 OD023696NIH HHS S10OD023696NIH HHS U54EB020403NIMH NIH HHS P50 MH066286NIMH NIH HHS R01 MH101506NIMH NIH HHS R01 MH113619NIMH NIH HHS R01 MH116147NIMH NIH HHS R01 MH117601NIMH NIH HHS R03 MH105808NIMH NIH HHS RF1 MH123163
6 · The paper itself

Abstract

Early-onset psychosis disorders are serious mental disorders arising before the age of 18 years. Here, we investigate the largest neuroimaging dataset, to date, of patients with early-onset psychosis and healthy controls for differences in intracranial and subcortical brain volumes. The sample included 263 patients with early-onset psychosis (mean age: 16.4 ± 1.4 years, mean illness duration: 1.5 ± 1.4 years, 39.2% female) and 359 healthy controls (mean age: 15.9 ± 1.7 years, 45.4% female) with magnetic resonance imaging data, pooled from 11 clinical cohorts. Patients were diagnosed with early-onset schizophrenia (n = 183), affective psychosis (n = 39), or other psychotic disorders (n = 41). We used linear mixed-effects models to investigate differences in intracranial and subcortical volumes across the patient sample, diagnostic subgroup and antipsychotic medication, relative to controls. We observed significantly lower intracranial (Cohen's d = -0.39) and hippocampal (d = -0.25) volumes, and higher caudate (d = 0.25) and pallidum (d = 0.24) volumes in patients relative to controls. Intracranial volume was lower in both early-onset schizophrenia (d = -0.34) and affective psychosis (d = -0.42), and early-onset schizophrenia showed lower hippocampal (d = -0.24) and higher pallidum (d = 0.29) volumes. Patients who were currently treated with antipsychotic medication (n = 193) had significantly lower intracranial volume (d = -0.42). The findings demonstrate a similar pattern of brain alterations in early-onset psychosis as previously reported in adult psychosis, but with notably low intracranial volume. The low intracranial volume suggests disrupted neurodevelopment in adolescent early-onset psychosis.

Indexed as

AdolescentAdolescent DevelopmentAffective Disorders, PsychoticAge of OnsetBrainGlobus PallidusHippocampusHumansMagnetic Resonance ImagingPsychotic DisordersSchizophreniaadolescenceantipsychoticsbrain structureearly-onsetintracranial volumepsychosis spectrum

Identifiers

PMID33017498
PMCPMC8675418
OpenAlexW3090788608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.